×
About 2,930 results

ALLMedicine™ Atrial Flutter Center

Research & Reviews  852 results

Increased incidence of cavotricuspid isthmus atrial flutter following slow pathway abla...
https://doi.org/10.1007/s10840-021-01065-0 10.1016/S0735-1097(00)00982-7 10.1016/S0735-1097(85)80497-6 10.15420/aer.2017:5:2 10.1016/0735-1097(93)90818-L 10.1016/0002-9149(93)90794-D 10.1053/euhj.1998.1337 10.1111/j.1540-8159.2005.00271.x 10.1253/circj.70.1133 10.1093/europace/euv345 10.1159/000365418 10.1093/eurheartj/ehx101
Journal of Interventional Cardiac Electrophysiology : an ... Varela DL, Rosenberg MA et. al.

Sep 18th, 2021 - The incidence of atrial flutter following radiofrequency ablation of supraventricular tachycardias is poorly understood. Ablation of atrioventricular nodal reentry tachycardia may place patients at risk of flutter because ablation of the slow path...

Heart failure and atrial flutter: a systematic review of current knowledge and practices.
https://doi.org/10.1002/ehf2.13526
ESC Heart Failure; Diamant MJ, Andrade JG et. al.

Sep 11th, 2021 - While the interplay between heart failure (HF) and atrial fibrillation (AF) has been extensively studied, little is known regarding HF and atrial flutter (AFL), which may be managed differently. We reviewed the incidence, prevalence, and predictor...

Comparative efficacy and safety of different catheter ablation strategies for persisten...
https://doi.org/10.1093/ehjqcco/qcab066
European Heart Journal. Quality of Care & Clinical Outcomes; Saglietto A, Ballatore A et. al.

Sep 10th, 2021 - Whereas pulmonary vein isolation (PVI) is the universally agreed target in catheter ablation of paroxysmal AF, an ideal ablation set in persistent AF remains questioned. Aim of this study is to conduct a network meta-analysis (NMA) of randomized c...

In acute atrial flutter, adding pharmacologic before electrical cardioversion did not i...
https://doi.org/10.7326/ACPJ202109210-105
Annals of Internal Medicine; Sampson C

Sep 7th, 2021 - Stiell IG, Sivilotti MLA, Taljaard M, et al. A randomized, controlled comparison of electrical versus pharmacological cardioversion for emergency department patients with acute atrial flutter. CJEM. 2021;23:314-24. 33959925.

Adverse events associated with electrical cardioversion in patients with acute atrial f...
https://doi.org/10.1016/j.cjca.2021.08.018
The Canadian Journal of Cardiology; Stiell IG, Eagles D et. al.

Sep 3rd, 2021 - We sought to evaluate safety of electrical cardioversion (ECV) for patients with acute atrial fibrillation (AF) or atrial flutter (AFL) in the emergency department (ED). This was an analysis of data from four multicentre AF/AFL studies conducted b...

see more →

Guidelines  3 results

2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults Wi...
https://doi.org/10.1016/j.jacc.2020.08.037
Journal of the American College of Cardiology; Heidenreich PA, Estes NAM et. al.

Dec 12th, 2020 - 2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.|2020|Hei...

Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stro...
https://doi.org/10.1016/j.cjca.2010.11.007
The Canadian Journal of Cardiology; Cairns JA, Connolly S et. al.

Feb 19th, 2011 - The stroke rate in atrial fibrillation is 4.5% per year, with death or permanent disability in over half. The risk of stroke varies from under 1% to over 20% per year, related to the risk factors of congestive heart failure, hypertension, age, dia...

ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalv...
https://doi.org/10.1161/CIRCULATIONAHA.107.187192
Circulation Estes NA, Halperin JL et. al.

Feb 20th, 2008 - ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the...

see more →

Drugs  180 results see all →

Clinicaltrials.gov  2 results

Apple Watch-led Surveillance of AF Recurrence After Catheter Ablation
https://clinicaltrials.gov/ct2/show/NCT05016791

Aug 23rd, 2021 - Atrial fibrillation (AF) is a heart rhythm disorder associated with debillitating symptoms, psychological distress and heart failure. It can also significantly increase an individuals stroke risk. Catheter ablation (CA) for AF is the most effectiv...

Assessment of the Effects of Long-term Lipid-lowering Therapy in Patients With Primary STEMI or NSTEMI
https://clinicaltrials.gov/ct2/show/NCT04347434

May 11th, 2021 - Methods Blood chemistry test. Total cholesterol, LDL, HDL, triglycerides, AST, ALT, CPK, glucose, CRP, creatinine, glycosylated hemoglobin 2D and 3D transthoracic echocardiography (Vivid GE 95 Healthcare (USA). 3D speckle echocardiography (3DSTE) ...

see more →

News  134 results

Hillmen Highlights Acalabrutinib’s Tolerability Vs Ibrutinib in Previously Treated CLL
https://www.onclive.com/view/hillmen-highlights-acalabrutinib-s-tolerability-vs-ibrutinib-in-frontline-cll

Jun 12th, 2021 - The next-generation, selective BTK inhibitor acalabrutinib (Calquence) demonstrated noninferiority to ibrutinib (Imbruvica) in terms of progression-free survival (PFS) in patients with previously treated chronic lymphocytic leukemia (CLL) in the p...

AF at COVID-19 Admission Predicts Mortality, Demands Vigilance
https://www.medscape.com/viewarticle/944802

Jan 27th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Short-term mortality climbs sharply for patients hospitalized with COVID-19 found to have atrial fibrillation (AF), especially new-onset AF, which...

Idasanutlin Induces Responses in Polycythemia Vera, but GI AEs Lead to Frequent Dose Interruptions
https://www.onclive.com/view/idasanutlin-induces-responses-in-polycythemia-vera-but-gi-aes-lead-to-frequent-dose-interruptions

Dec 22nd, 2020 - Idasanutlin, an investigational MDM2 antagonist that leads to increased p53 activity, led to hematologic responses in about two-thirds of patients with hydroxyurea (HU)-resistant polycythemia vera (PV), but was associated with frequent discontinua...

ViPOR Regimen Is Safe, Shows Impressive Activity in Relapsed/Refractory DLBCL
https://www.onclive.com/view/vipor-regimen-is-safe-shows-impressive-activity-in-relapsed-refractory-dlbcl

Dec 21st, 2020 - The 5-drug regimen of venetoclax (Venclexta), ibrutinib (Imbruvica), prednisone, obinutuzumab (Gazyva), and lenalidomide (Revlimid; ViPOR) showed a tolerable safety profile and encouraging antitumor activity with complete responses (CRs) in patien...

ACC/AHA Update Two Atrial Fibrillation Performance Measures
https://www.medscape.com/viewarticle/942439

Dec 10th, 2020 - The American College of Cardiology (ACC) and American Heart Association (AHA) Task Force on Performance Measures have made two changes to performance measures for adults with atrial fibrillation or atrial flutter. The 2020 Update to the 2016 ACC/A...

see more →

Patient Education  1 results see all →